Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Stefano Fogli

1-14 of 14 results

Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients

scientific article published on May 2002

Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study*

scientific article published on July 1, 2001

Rosiglitazone reverses salbutamol-induced β(2) -adrenoceptor tolerance in airway smooth muscle

scientific article published on January 2011

Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer

scientific article published on 28 June 2018

Synergistic interaction between PPAR ligands and salbutamol on human bronchial smooth muscle cell proliferation

scientific article published on January 1, 2013

Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells

scientific article published on 25 January 2017

Clinical pharmacology of intravitreal anti-VEGF drugs.

scientific article

Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients

scientific article published on 26 July 2019

Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting.

scientific article published on 31 August 2016

Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells

scientific article

The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer

scientific article published on 06 December 2018

Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells

scholarly article by Irene Banti et al published 1 August 2009 in Journal of Pharmacy and Pharmacology

Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors

scientific article published on 19 January 2019

Salbutamol inhibits RhoA activation in normal but not in desensitized bronchial smooth muscle cells

scientific article published on June 16, 2015